The PPARβ/δ agonist GW0742 modulates signaling pathways associated with cardiac myocyte growth via a non-genomic redox mechanism

Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev Mol Cell Biol 7:589–600 Clerk A, Cullingford TE, Fuller SJ, Giraldo A, Markou T, Pikkarainen S et al (2007) Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses. J Cell Physiol 212:311–322 Rohini A, Agrawal N, Koyani CN, Singh R (2010) Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 61(4):269–280 Ceci M, Ross J Jr, Condorelli G (2004) Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT. J Mol Cell Cardiol 37:905–912 Matsui T, Rosenzweig A (2005) Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 38:63–71 Vanhaesebroeck B, Alessi DR (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346:561–576 Markou T, Barlaka E, Bartucci M, Lazou A (2011) Signal transduction pathways through cytoprotective, apoptotic and hypertrophic stimuli: a comparative study in adult cardiac myocytes. Cell Biochem Funct 29(6):442–451 Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J et al (2001) Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 89(5):453–460 Inagi R (2006) Oxidative stress in cardiovascular disease: a new avenue toward future therapeutic approaches. Recent Pat Cardiovasc Drug Discov 1(2):151–159 Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49(2):241–248 Yang Q, Li Y (2007) Roles of PPARs on regulating myocardial energy and lipid homeostasis. J Mol Med (Berl) 85(7):697–706 Ravingerova T, Adameova A, Carnicka S, Nemcekova M, Kelly T, Matejikova J et al (2011) The role of PPAR in myocardial response to ischemia in normal and diseased heart. Gen Physiol Biophys 30(4):329–341 Lotz C, Lazariotto M, Redel A, Smul Tm, Stumpner J, Blomeyer C et al (2011) Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo. Exp Biol Med 236:113–122 Ravingerová T, Carnická S, Nemčeková M, Ledvényiová V, Adameová A, Kelly T et al (2012) PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury: involvement of PI3K-Akt. Can J Physiol Pharmacol 90(8):1135–1144 Barlaka E, Ledvényiová V, Galatou E, Ferko M, Čarnická S, Ravingerová T, Lazou A (2013) Delayed cardioprotective effects of WY-14643 are associated with inhibition of MMP-2 and modulation of Bcl-2 family proteins through PPAR-α activation in rat hearts subjected to global ischaemia-reperfusion. Can J Physiol Pharmacol 91(8):608–616 Inoue I, Goto S, Matsunaga T, Nakajima T, Awata T, Hokari S, Komoda T, Katayama S (2001) The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50(1):3–11 Smeets PJH, Planavila A, Van Der Vusse GJ, Van Bilsen M (2007) Peroxisome proliferator-activated receptors and inflammation: take it to heart. Acta Physiol 191:171–188 Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N et al (2004) Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10(11):1245–1250 Planavila A, Rodriguez-Calvo R, Jove M, Michalik L, Wahli W (2005) Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc Res 65(4):832–841 Sheng L, Ye P, Liu YX, Han CG, Zhang ZY (2008) Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro. Clin Exp Hypertens 30(2):109–119 Pesant M, Sueur S, Dutartre P, Tallandier M, Grimaldi PA, Rochette L, Connat JL (2006) Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis. Cardiovasc Res 1 69(2):440–449 Sznaidman ML, Haffner CD, Maloney PR, Fivush A, Chao E, Goreham D et al (2003) Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta) synthesis and biological activity. Bioorg Med Chem Lett 13(9):1517–1521 Shearer BG, Steger DJ, Way JM, Stanley TB, Lobe DC, Grillot DA et al (2008) Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol Endocrinol 22(2):523–529 Markou T, Dowling AA, Kelly T, Lazou A (2009) Regulation of Bcl-2 phosphorylation in response to oxidative stress in cardiac myocytes. Free Radic Res 43(9):809–816 Markou T, Lazou A (2002) Phosphorylation and activation of mitogen- and stress-activated protein kinase-1 in adult rat cardiac myocytes by G-protein-coupled receptor agonists requires both extracellular-signal-regulated kinase and p38 mitogen-activated protein kinase. Biochem J 365:757–763 Markou T, Hadzopoulou-Cladaras M, Lazou A (2004) Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways. J Mol Cell Cardiol 37:1001–1011 Markou T, Cieslak D, Gaitanaki C, Lazou A (2009) Differential roles of MAPKs and MSK1 signalling pathways in the regulation of c-Jun during phenylephrine-induced cardiac myocyte hypertrophy. Mol Cell Biochem 322(1–2):103–112 Palm-Leis A, Singh SU, Herbelin SB, Olsovsky DG, Baker MK, Pan J (2004) Mitogen-activated protein kinases and mitogen-activated protein kinase phosphatases mediate the inhibitory effects of all-trans retinoic acid on the hypertrophic growth of cardiomyocytes. J Biol Chem 279(52):54905–54917 Shah BH, Olivares-Reyes JA, Catt KJ (2005) The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. Mol Pharmacol 67(1):184–194 Finkel T (2003) Oxidant signals and oxidative stress. Curr Opin Cell Biol 15:247–254 Lee SR, Yang KS, Kwon J, Lee C, Jeong W, Rhee SG (2002) Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277(23):20336–20342 Burgoyne RJ, Mongue-Din H, Eaton P, Shah MA (2012) Redox signaling in cardiac physiology and pathology. A Rev Circ Res 111:1091–1106 Seo JH, Ahn Y, Lee SR, Yeol YC, Chung HK (2005) The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol Biol Cell 16(1):348–357 Liang F, Wang F, Zhang S, Gardner DG (2003) Peroxisome proliferator activated receptor (PPAR) alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes. Endocrinology 144(9):4187–4194 Planavila A, Laguna JC, Vázquez-Carrera M (2005) Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation. Biochim Biophys Acta 1687(1–3):76–83 Bao Y, Li R, Jiang J, Cai B, Gao J, Le K et al (2008) Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway. Mol Cell Biochem 317(1–2):189–196 Lazou A, Sugden PH, Clerk A (1998) Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart. Biochem J 332(2):459–465 Huang Y, Zhang H, Shao Z, O’Hara KA, Kopilas MA, Yu L et al (2011) Suppression of endothelin-1-induced cardiac myocyte hypertrophy by PPAR agonists: role of diacylglycerol kinase zeta. Cardiovasc Res 90(2):267–275 Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103(2):211–225 Saxena M, Mustelin T (2000) Extracellular signals and scores of phosphatases: all roads lead to MAP kinase. Semin Immunol 12:387–396 Meng TC, Fukada T, Tonks NK (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9(2):387–399 Ostman A, Frijhoff J, Sandin A, Böhmer FD (2011) Regulation of protein tyrosine phosphatases by reversible oxidation. J Biochem 150(4):345–356 Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ, Stadtman ER, Rhee SG (2004) Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci USA 101(47):16419–16424 Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, Downes CP (2003) Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 22(20):5501–5510 Liu J, Wang P, Luo J, Huang Y, He L, Yang H et al (2011) Peroxisome proliferator-activated receptor β/δ activation in adult hearts facilitates mitochondrial function and cardiac performance under pressure-overload condition. Hypertension 57(2):223–230